●At the 20th Clinical Endocrinology and Metabolism Update held on January 28-29, 2011 (Sapporo), Dr. Yoshiharu Wada from our department won the Outstanding Presentation Award for his presentation entitled "Characteristics of Lymphocytic Panhypophysitis in Japanese People."
http://www.youtube.com/watch?v=eLOh5GlkjNQ

●At the 20th Clinical Endocrinology and Metabolism Update held on January 28-29, 2011 (Sapporo), Dr. Yoshiharu Wada from our department won the Outstanding Presentation Award for his presentation entitled "Characteristics of Lymphocytic Panhypophysitis in Japanese People."
http://www.youtube.com/watch?v=eLOh5GlkjNQ

A new arrhythmia department has been established at the Kitano Hospital Cardiac Center. Many people may still be unfamiliar with the term arrhythmia department.

When you hear the term arrhythmia, what do you imagine?

Do you have impressions such as "palpitations," "abnormal electrocardiograms," and "sudden death"?

"Arrhythmia" is one of the symptoms of heart disease, and is known to be related to many other heart diseases. It has been reported that nearly 40% of outpatients with cardiovascular diseases have problems related to arrhythmia. Research into arrhythmia has also progressed rapidly, with significant progress over the past decade.

On the other hand, because information related to arrhythmia is specialized and complex, misconceptions and outdated thinking can lead to problems such as "causing unnecessary worry to patients" and "not providing appropriate treatment."

In this situation, the presence of specialists with extensive experience in arrhythmias is becoming essential in facilities providing advanced, specialized medical care for cardiovascular diseases, both in Japan and overseas. Therefore, there is a trend toward establishing arrhythmia departments to provide more specialized arrhythmia treatment. In response to this situation, our Heart Center has also decided to establish a new arrhythmia department specializing in arrhythmia treatment.

Now, let me introduce some of the specific treatments we offer.

Specialized Treatment

With the support of the Cardiovascular Surgery Department and the introduction of cutting-edge equipment such as the CART system, catheter ablation treatment for tachyarrhythmias such as atrial fibrillation and ventricular tachycardia began in April 2008. This treatment can be a more fundamental treatment than drug therapy, and has been performed in nearly 200 cases to date. We have also introduced implantable cardioverter-defibrillator surgery for life-threatening ventricular arrhythmias and cardiac synchronized therapy for severe heart failure.

Advanced Medical Care

We participate in large-scale clinical trials both in Japan and overseas, and are involved in creating new guidelines for arrhythmia treatment. Furthermore, we are collaborating with Kyoto University Graduate School and Shiga University of Medical Science to conduct genetic research into arrhythmia-related diseases and clarify the relationship between genetic abnormalities and clinical arrhythmias. We are utilizing the results of these research in our clinical practice.

Finally, while arrhythmia is one of the important symptoms of heart disease, at the Kitano Hospital Cardiac Center Arrhythmia Department, we do not limit ourselves to arrhythmia alone; we take a deeper look at each patient's background and provide medical care without relying solely on invasive treatments. If you have any problems related to arrhythmia, please feel free to consult us.

We have an arrhythmia outpatient clinic on Tuesdays, but if you have any other questions, please feel free to contact us directly and we will respond as soon as possible.

Kitano Hospital Cardiac Center, Chief of Arrhythmia
Tetsuya Haruna

●An interview with Koshiyama was published in the January 15th issue of Weekly Post.

●当センター長　越山医師のインタビュー記事が月刊誌「一個人」2月号（KKベストセラーズ）に掲載されました。
掲載記事：「糖尿病医療を変える　期待のインクレチン関連経口薬」

●当センターの佐藤運動生理学講師がACSM(アメリカスポーツ医学会）の発行するHealth & Fitness Jornalの2011Trend特集の中で、International Expertsの一人として紹介されました。
http://journals.lww.com/acsm-healthfitness/Fulltext/2010/11000/Worldwide_Survey_of_Fitness_Trends_for_2011.6.aspx

Since November 2010, we have been providing lunch at Hotel New Otani Osaka to those who undergo health checkups, and after lunch, we have started offering dietary classes led by a registered dietitian on how to prevent lifestyle-related diseases.

<Dietary guidance by a registered dietitian>

<Lunch at Hotel New Otani Osaka>

This is a special menu for health-conscious patients undergoing medical checkups at Kitano Hospital.
It uses plenty of vegetables and 29 different ingredients.
(Calories: approx. 700kcal, Salt: approx. 4g)

*The menu may change slightly depending on the season.

Dr. Koshiyama was invited to give a lecture at Steno Diabetes, a world-famous diabetes center in Denmark, on November 16-17. Koshiyama H. “Status of Diabete Mellitus in Japan - Clinical Research, Incretin-based Therapy and New Paradigm-” Special Lecture in Steno Diabetes Center 2010.11.16 (Steno Diabetes Center, Cphenhagen, Denmark)

●下記の要領で10月23日、初めての試みとして国際糖尿病内分泌看護セミナーを行いました。多数お集まり頂き、大変好評でした。御礼を申し上げます。今後もこのような活動を続ける予定ですので、またご参集ください。
The INTERNATIONAL KITANO Nurse Diabetes & Endo SEMINAR （IKNDES）
日　　時 ：平成22年10月23日(土）　15：00〜17：00
場　　所 ：北野病院　きたのホール
special lecture
（座長）　大阪大学大学院医学系研究科保健学専攻　准教授
　　　 　　瀬戸　奈津子　先生
"NP in the USA: Past, Present and Future"
　　Community Hospital of the Monterey Peninsula　FNP (Family Nurse Practitioner） 　　Eri Matsumoto　先生

Symposium
（司会）
Director of the Diabetes and Endocrinology Center, Kitano Hospital, Medical Research Institute, Tatsunokofukai Foundation
Dr. Hiroyuki Koshiyama
（テーマ）
"The Role and Potential of Nurses in Diabetes Care"
（パネリスト）
　・Community Hospital of the Monterey Peninsula FNP
　 　(Family Nurse Practitioner） 　松本　恵理　先生
　・Harden Urgent Care Medical Center Alfred M. Sadler Jr. MD
　　大阪大学大学院医学系研究科
　　保健学専攻　准教授 　瀬戸　奈津子 先生
　・国際医療福祉大学大学院　看護学分野　看護管理・開発学領域
　　(保健医療学専攻)　教授 　湯沢　八江　先生
　・(財)田附興風会　医学研究所　 北野病院　看護部　師長
　　中山　法子　看護師

●越山医師がEditor-in-Chiefのオープン雑誌が創刊しました。症例報告、ミニリビューも歓迎ですので、投稿ください。
http://www.la-press.com/japanese-clinical-medicine-journal-j172

●Kitano Hospital was featured in the ranking of endocrine system patients.

　http://hospia.jp/toplst/?id=10
[Source] Data reported by the Medical Fee Survey Specialist Organization, DPC Evaluation Subcommittee

Adiponectin is a beneficial hormone secreted by fat cells and is reduced in obese people. Adiponectin has the effect of suppressing arteriosclerosis and improving the effects of insulin, and is also reduced in ischemic heart disease and diabetes. It is known that reduced adiponectin levels also increase when obesity is improved through exercise, etc., making adiponectin measurement useful as a new indicator of metabolic syndrome.

Adiponectin measurement 10,000 yen

Total cholesterol and LDL cholesterol are measured as indicators of arteriosclerosis, but arteriosclerosis actually occurs when oxidized LDL, or oxidized LDL, is taken up by the intima of the arterial wall, and it can be said that oxidized LDL is a risk factor for arteriosclerosis. It has also been reported that oxidized LDL levels are elevated in patients with myocardial infarction and angina pectoris. Oxidized LDL is useful as a new indicator of arteriosclerosis.

Oxidized LDL measurement: 2,000 yen